Digital Health Partnerships Marius has already demonstrated success distributing KYZATREX through digital health platforms with Hims and Hers and through The Vitamin Shoppe's Whole Health Rx telehealth service. This shows a scalable path via additional telehealth networks and specialty pharmacies. Sales opportunities include onboarding endocrinology and urology clinics, building joint marketing programs, and offering patient monitoring support to expand access to FDA approved TRT therapy.

Canada Market Expansion Health Canada approval for KYZATREX opens a cross border growth avenue. Engage Canadian providers, clinics, and payers through localized partnerships and regulatory aligned pricing and access programs. Opportunities exist to accelerate adoption via provincial health networks, physician education, and co marketing with local distributors.

Education Led Growth Marius is pursuing disease state awareness through initiatives like ReThink Testosterone and collaborated market research with YouGov. This education focus drives patient demand and provider engagement. Sales potential lies in offering clinician and patient education packages, co branded campaigns, and patient support programs that convert awareness into prescriptions.

Data Driven Insights Active use of market research partnerships positions Marius to monetize insights for partners and payors. A data driven collaboration program could include market segmentation reports, channel performance analytics, and real world evidence generation to support favorable reimbursement discussions and targeted sales efforts.

Cost Savings Positioning Marius frames its mission around reducing unnecessary costs in the health care system by treating testosterone deficiency more effectively. This positions KYZATREX as a payor friendly therapy with potential for formulary inclusion. Proposals could focus on health economic analyses, real world outcomes, and partnerships with hospitals and insurers to demonstrate value.